LiquidHALLMARK
Commercial- Indications
- Multiple cancer types
Company intelligence / Profile preview
Lucence
Singapore, Singaporelucence.com ↗
- Ownership
- Private
- Employees
- ~73
- Development stage
- Commercial
01
Overview
Lucence’s liquid biopsy tests have demonstrated >99% sensitivity for detecting clinically relevant biomarkers at low mutant allele frequencies. Their combined DNA/RNA approach improves diagnostic yield. The company’s LiquidHALLMARK® test has received Medicare coverage in the US for lung cancer testing and supports treatment selection across multiple tumor types. Clinical collaborations include studies with Mayo Clinic Laboratories and Veterans' Affairs Health Care System.
- Therapeutic areas
- OncologyHematology
- Modalities
- Liquid biopsy (combining ctDNA and ctRNA analysis)Next-generation sequencing (NGS)-based diagnostics
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Mayo Clinic Laboratories (strategic collaboration for enhanced US testing services)Quest Laboratories (Asia distribution)National Cancer Center Singapore (liquid biopsy development)Bangkok Molecular GeneticsSingapore DiagnosticsMascots Medical & Laboratory Centre—regional distribution partners in AsiaAstraZeneca Singapore (liquid BRCA testing collaboration)NovogeneAIR Genomics Singapore/AITbiotech JV—NGS-based precision medicine assays for Asia marketMEDx Translational Medicine China—co-development of companion diagnostics for PD-L1 rearrangement therapiesOmnigen Turkey—distribution partnership
Beyond the preview
Go deeper on Lucence.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lucence.